Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Himmelreich, Uwe ^a,e   Malik, Richard ^a   Kühn, Till ^b   Daniel, Heide Marie ^a,c   Somorjai, Ray L ^d   Dolenko, Brion ^d   Sorrell, Tania C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b BRUKER BIOSPIN AG   (Switzerland)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CITRIC ACID; GLUCOSE; LACTIC ACID; POLYOL;

ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; IMMUNE RESPONSE; INFLAMMATORY CELL; METABOLITE; MICROBIAL METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RAT; STREPTOCOCCUS PNEUMONIAE; ANIMAL; CEREBROSPINAL FLUID; CLASSIFICATION; FISCHER 344 RAT; METABOLOMICS; METHODOLOGY; PATHOGENICITY;

ANIMALIA; BACTERIA (MICROORGANISMS); RATTUS;

ANIMALS; CRYPTOCOCCUS NEOFORMANS; MAGNETIC RESONANCE SPECTROSCOPY; MENINGITIS, BACTERIAL; METABOLOMICS; RATS; RATS, INBRED F344; STREPTOCOCCUS PNEUMONIAE;

EID: 65449139122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005328     Document Type: Article

References (44)

1. Aronin SI, Peduzzi P, Quagliarello VJ (1998) Community-acquired meningitis. Risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 129: 862-869.
2. Lu CH, Huang CR, Chang WN (2002) Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors. Clin Neurol Neurosurg 104: 352-358.
3. Tunkel AR, Scheld WM (2000) Acute meningitis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone. pp 959-997.
4. De Gans J, Van de Beek D (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 347: 1549-1556.
5. Fishman R (1992) Cerebrospinal fluid in diseases of the nervous system. Philadelphia: WB Saunders.
6. Van de Beek D, De Gans J, Spanjaard L, Weisfelt M, Reitsma JB, et al. (2004) Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 351: 1849-1859.
7. Wood M, Anderson M (1998) Cerebrospinal fluid and infections of the central nervous system. In: Walton Sir J, ed. Major problems in Neurology. London: W.B. Saunders.
8. Coen M, O'Sullivan M, Bubb WA, Kuchel PW, Sorrell T (2005) Proton nuclear magnetic resonance - based metabonomics for rapid diagnosis of meningitis and ventriculitis. Clin Infect Dis 41: 1582-1590.
9. Mariey L, Signolle JP, Amiel C, Travert J (2001) Discrimination, classification, identification of microorganisms using FTIR spectroscopy and chemometrics. Vibrational Spectroscopy 26: 151-159.
10. Himmelreich U, Mountford CE, Sorrell TC (2004) NMR spectroscopic determination of microbiological profiles in infectious diseases. Trends Appl Spectrosc 5: 269-283.
11. Maquelin K, Kirschner C, Choo-Smith LP, van den Braak N, Endtz HP, et al. (2002) Identification of medically relevant microorganisms by vibrational spectroscopy. Journal of Microbiological Methods 51: 255-271.
12. Fenselau C, Demirev PA (2001) Characterization of intact microorganisms by MALDI mass spectrometry. Mass Spectrometry Reviews 20: 157-171.
13. Allen JK, Davey HM, Broadhurst D, Heald JK, Rowland JJ, et al. (2003) High-throughput characterisation of yeast mutants for functional genomics using metabolic footprinting. Nature Biotechnology 21: 692-696.
14. Raamsdonk LM, Teusink B, Broadhurst D, Zhang N, Hayes A, et al. (2001) A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nature Biotechnology 19: 45-50.
15. Dunn WB, Bailey NJC, Johnson HE (2005) Measuring the metabolome: current analytical technologies. Analyst 130: 606-625.
16. Himmelreich U, Somorjai RL, Dolenko B, Lee OC, Daniel HM, et al. (2003) Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy. Appl Environ Microbiol 69: 4566-4674.
17. Pope GA, MacKenzie DA, Defernez M, Aroso MAMM, Fuller LJ, et al. (2007) Metabolic footprinting as a tool for discriminating between brewing yeasts. Yeast 24: 667-679.
18. Urbanczyk-Wochniak E, Luedemann A, Kopka J (2003) Parallel analysis of transcript and metabolic profiles: a new approach in systems biology. EMBO Report 4: 989-993.
19. Nicholson JK, Wilson ID (1989) High resolution proton magnetic resonance spectroscopy of biological fluids. In: Emsley JW, Feeney J, eds. Progress in Nuclear Magnetic Resonance Spectroscopy. Oxford: Pergamon Press. pp 449-501.
20. Hiraoka A, Miura I, Hattori M, Tominaga I, Kushida K, et al. (1994) Proton magnetic resonance spectroscopy of cerebrospinal fluid as an aid in neurological diagnosis. Biol Pharm Bull 17: 1-4.
21. Nicoli F, Vion-Dury J, Maloteaux JM, Delwaide C, Confort-Gouny S, et al. (1993) CSF and serum metabolic profile of patients with Hungington's chorea: a study by high resolution proton NMR spectroscopy and HPLC. Neurosci Lett 154: 47-51.
22. Wevers RA, Engelke U, Wendel U, De Jong JGN, Gabreels FJM, et al. (1995) Standardized method for high resolution 1H-NMR of cerebrospinal fluid. Clin Chem 41: 744-751.
23. Hu Y, Malone JP, A.M. F, Townsend RR, Holtzman DM (2005) Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol Cell Proteomics 4: 2000-2009.
24. Selle H, Lamerz J, Buerger K, Dessauer A, Hager K, et al. (2005) Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease. Comb Chem High Troughput Screen 8: 801-806.
25. Dekker LJ, Boogerd W, Stockhammer G, Dalebout JC, Siccama I, et al. (2005) MALDI-TOF mass spectrometry analysis of cerebrospinal fluid tryptic peptide profiles to diagnose leptomeningeal metastases in patients with breast cancer. Mol Cell Proteomics 4: 1341-1349.
26. Pfyffer GE, Kissling P, Jahn EMI, Welscher HM, Salfinger M, et al. (1996) Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens. J Clin Microbiol 34: 834-841.
27. Lewczuk P, Esselmann H, Meyer M, Wollscheid V, Neumann M, et al. (2003) The amyloid-beta (A beta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated A beta peptide. Journal of Rapid Communications in Mass Spectrometry 17: 1291-1296.
28. Yuan X, Desiderio DM (2005) Human cerebrospinal fluid peptidomics. J Mass Spectrom 40: 176-181.
29. Maillet S, Vion-Dury J, Confort-Gouny S, Nicoli F, Lutz NW, et al. (1998) Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. Brain Res Protoc 3: 123-134.
30. Bell JD, Brown JC, Sadler PJ, Macleod AF, Sonksen PH, et al. (1987) High resolution proton nuclear magnetic resonance studies of human cerebrospinal fluid. Clin Sci 72: 563-570.
31. Levine J, Panchalingam K, McClure RJ, Gershon S, Pettegrew JW (2000) Stability of CSF metabolites measured by proton NMR. J Transm 107: 843-848.
32. Griffin JL, Nicholls AW, Keun HC, Mortishire-Smith RJ, Nicholson JK, et al. (2002) Metabolic profiling of rodent biological fluids via H-1 NMR spectroscopy using a 1 mm microlitre probe. Analyst 127: 582-584.
33. Schlotterbeck G, Ross A, Hochstrasser R, Senn H, Kuehn T, et al. (2002) Highresolution capillary tube NMR. A miniaturized 5 ul high-sensitivity TXI probe for mass-limited samples, off-line LC NMR, and HT NMR. Anal Chem 74: 4464-4471.
34. Nikulin AE, Dolenko B, Bezabeh T, Somorjai RL (1998) Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra. NMR Biomed 11: 209-216.
35. Himmelreich U, Accurso R, Malik R, Dolenko B, Somorjai RL, et al. (2005) Identification of Staphylococcus aureus brain abscesses: rat and human studies with 1 H MR spectroscopy. Radiology 236: 261-270.
36. Himmelreich U, Dzendrowskyj T, Allen C, Dowd S, Malik R, et al. (2001) Cryptococcomas distinguished from gliomas with magnetic resonance spectroscopy: an experimental rat and cell culture study. Radiology 220: 122-128.
37. Dunne VG, Bhattachayya S, Besser M, Rae C, Griffin JL (2005) Metabolites from cerebrospinal fluid in aneurysmal subarachnoid haemorrhage correlate with vasospasm and clinical outcome: a pattern-recognition 1H NMR study. NMR Biomed 18: 24-33.
38. Schlegel HG (1992) Allgemeine Mikrobiologie. Stuttgart: Georg Thieme Verlag.
39. Himmelreich U, Allen C, Dowd S, Malik R, Shehan BP, et al. (2003) Magnetic Resonance Spectroscopy of rat lung cryptococcomas identifies compounds of importance in pathogenesis. Microbes Infect 5: 285-290.
40. Subramanian A, Gupta A, Saxena S, Kumar R, Nigam A, et al. (2005) Proton MR CSF analysis and a new software as predictors for the differentiation of meningitis in children. NMR Biomed 18: 213-225.
41. Palmer III AG, Cevanagh J, Wright PE, Rance M (1991) J Magn Reson 93: 151-170.
42. Somorjai RL, Baumgartner R, Booth S, Bowman C, Demko A, et al. (2004) A data-driven, flexible machine learning strategy for the classification of biomedical data. In: Dubitzky W, Azuaje F, eds. Artificial intelligence methods and tools for systems biology. Berlin: Springer. pp 67-85.
43. Somorjai RL, Dolenko B, Nikulin AE, Nickerson P, Rush D, et al. (2002) Distinguishing normal from rejecting renal allografts: Application of a three stage classification strategy to MR and IR spectra of urine. Vib Spectrosc 28: 97-102.
44. Efron B, Tibshirani R (1993) An introduction to the bootstrap. New York: Chapman & Hall.